Article Information
History
- September 23, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Aleksandra Stanojevic1,
- Jelena Spasic2,
- Mladen Marinkovic3,
- Suzana Stojanovic-Rundic3,4,
- Radmila Jankovic1,
- Ana Djuric1,
- Jerome Zoidakis5,6,
- Remond J.A. Fijneman7,
- Sergi Castellvi-Bel8 and
- Milena Cavic1,*
- 1Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
- 2Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
- 3Clinic for Radiation Oncology and Diagnostics, Department of Radiation Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
- 4Faculty of Medicine, University of Belgrade, Belgrade, Serbia
- 5Department of Biotechnology, Biomedical Research Foundation, Academy of Athens, Athens, Greece
- 6Department of Biology, National and Kapodistrian University of Athens, Athens, Greece
- 7Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands
- 8Gastroenterology Department, Fundació Recerca Clínic Barcelona-Institutd’Investigacions Biomèdiques August Pi iSunyer, Centro de Investigación Biomédicaen Red de Enfermedades Hepáticas y Digestivas, Clínic Barcelona, University of Barcelona, Barcelona, Spain
- ↵*Corresponding author: Milena Cavic, Ph.D. Institute for Oncology and Radiology of Serbia, Department of Experimental Oncology Pasterova 14, 11000 Belgrade, Serbia Phone number: + 381 11 2067284 E-mail: milena.cavic{at}ncrc.ac.rs